Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE (SPEED)
SPEED 1 Trial: Bridge to Orthotopic Liver Transplantation (OLT) - (Surefire Precision vs Endhole Embolization With DEBTACE)
Sponsor: Surefire Medical, Inc.
Terminated
Sponsor withdrew funding
Other terminated trials from Surefire Medical, Inc.
- Hepatocellular Carcinoma · Phase NA · Dec 2018
- Hepatocellular Carcinoma · Jun 2018
- Hepatocellular Carcinoma · Phase NA · Jun 2018
More terminations from Surefire Medical, Inc.
A NA clinical study on Hepatocellular Carcinoma of the Liver and Subjects Eligible for Liver Transplantation, this trial is terminated or withdrawn. The trial is conducted by Surefire Medical, Inc. and has accumulated 8 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Feb 2022 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Feb 2022 [monthly]
Terminated NA
-
Feb 2020 — Jan 2021 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Nov 2018 — Feb 2020 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jul 2018 — Nov 2018 [monthly]
Recruiting NA
-
Jul 2017 — Jul 2018 [monthly]
Recruiting NA
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Surefire Medical, Inc.
- University of Colorado, Denver
For direct contact, visit the study record on ClinicalTrials.gov .